Avoid When taken for a long period of time, abrupt discontinuation is highly unadvised. Avoid combining other depressants such as Alcohol.
Chemical Name

Alprazolam

Aliases

xanax, prazolam, ksalol, niravam

Categories

Benzodiazepine, Habit-forming, Depressant, Common

Summary

An extremely common benzodiazepine better known as Xanax, frequently prescribed for the treatment of anxiety and panic disorders. Alprazolam is short-lasting and primarily anxiolytic, though also possesses hypnotic properties. At high doses amnesia and loss of inhibition are common. Do not mix with other depressants.

Bioavailability

Oral 80-90%

Dose to diazepam

Alprazolam - 0.5mg ~=10mg Diazepam.

Dosage Note

NOTE: Warning - higher doses increase the chances of blacking out

Dosages
Oral (mg)Oral (mg)3.03.02.52.52.02.01.51.51.01.00.50.50.00.0
Light
Common
Strong
Heavy
Download SVG
Download PNG
Download CSV

Light

Common

Strong

Heavy

Oral

0.25-0.5mg

0.5-1.5mg

1.5-2mg

2mg

Durations
OralOral404030302020101000
Onset
Duration
After Effects
Download SVG
Download PNG
Download CSV

Onset

Duration

After Effects

Oral

15m to 40m

5 to 8

6 to 24

Effects

Anxiolytic, Sedative, Muscle Relaxant, Amnesia, Dystaxia, Hiccups, Loss of time, Loss of motor skills

Sources

Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam. - https://www.ncbi.nlm.nih.gov/pubmed/11226811tability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids. - http://www.ncbi.nlm.nih.gov/pubmed/9784772Alprazolam-related deaths in Palm Beach County. -http://www.ncbi.nlm.nih.gov/pubmed/15725773Alprazolam kinetics following sublingual and oral administration. - http://www.ncbi.nlm.nih.gov/pubmed/3680603A fatal case of Benzodiazepine withdrawal. - https://www.ncbi.nlm.nih.gov/pubmed/19465812Pregnancy category D according to the FDA with potential to do genetic damage. - http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018276s044,021434s006lbl.pdf